Arcutis Biotherapeutics

Filed a patent for "method for reducing side effects from administration of phosphodiesterase-4 inhibitors" on Thu, November 14, 2024

Filed a patent for "pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug" on Thu, September 15, 2022

Filed a patent for "self-preserving topical pharmaceutical compositions comprising diethylene glycol monoethyl ether" on Thu, September 14, 2023

Filed a patent for "treatment of skin conditions using high krafft temperature anionic surfactants" on Thu, May 4, 2023

Filed a patent for "pharmaceutical compositions of spironolactone for deep dermal drug delivery" on Thu, May 11, 2023

Filed a patent for "pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents" on Thu, March 23, 2023

Filed a patent for "stable formulations of shr0302" on Thu, June 15, 2023

Filed a patent for "topical aerosol foams" on Thu, June 22, 2023

Filed a patent for "topical roflumilast formulation having improved delivery and plasma half- life" on Thu, October 5, 2023

Filed a patent for "compositions and methods for deep dermal drug delivery" on Thu, July 20, 2023

Filed a patent for "compositions and methods for deep dermal drug delivery" on Thu, December 28, 2023

Filed a patent for "self-preserving topical pharmaceutical compositions comprising diethylene glycol monoethyl ether" on Thu, October 5, 2023

Filed a patent for "topical roflumilast formulation having antifungal properties" on Thu, October 12, 2023

Filed a patent for "laureth-4 containing topical formulations" on Thu, October 26, 2023

Filed a patent for "method and formulation for improving roflumilast skin penetration lag time" on Thu, November 2, 2023

Filed a patent for "method and formulation for improving roflumilast skin penetration lag time" on Thu, October 26, 2023

Filed a patent for "method and formulation for improving roflumilast skin penetration lag time" on Thu, November 2, 2023

Filed a patent for "pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug" on Thu, April 4, 2024

Filed a patent for "method for reducing side effects from administration of phosphodiesterase-4 inhibitors" on Thu, January 25, 2024

Filed a patent for "topical roflumilast formulation having improved delivery and plasma half- life" on Thu, November 16, 2023

Filed a patent for "roflumilast formulations with an improved pharmacokinetic profile" on Thu, January 4, 2024

Filed a patent for "inhibition of crystal growth of roflumilast" on Thu, December 28, 2023

Filed a patent for "roflumilast formulations with an improved pharmacokinetic profile" on Thu, July 4, 2024

Filed a patent for "treatment of skin conditions using high krafft temperature anionic surfactants" on Thu, August 8, 2024

Filed a patent for "topical roflumilast formulation having improved delivery and plasma half- life" on Thu, August 29, 2024